Xebio Holdings will allocate 2,180 stock acquisition rights to 58 individuals on June 12, 2026, with an exercise period from June 13, 2028, to June 12, 2033. The purpose is to incentivize performance improvement and increase corporate value.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"8281","jir_company_name":"Xebio Holdings Co., Ltd.","jir_importance":"\u2605\u2605\u2606\u2606\u2606","jir_publication_date":"2026-06-05","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/06\/8281-20260605-01.pdf","jir_short_summary":"Xebio Holdings will allocate 2,180 stock acquisition rights to 58 individuals on June 12, 2026, with an exercise period from June 13, 2028, to June 12, 2033. The purpose is to incentivize performance improvement and increase corporate value.","jir_summary":"### Details of the Stock Acquisition Rights Issuance\nXebio Holdings resolved at the Board of Directors meeting held on June 5, 2026, to allocate 2,180 stock acquisition rights to 58 individuals on June 12, 2026. The purpose is to incentivize directors and employees to improve performance and increase corporate value, with the exercise period from June 13, 2028, to June 12, 2033. No payment is required for exercise, and the number of shares and exercise price may be adjusted.\n\n### Purpose and Future Outlook\nThis stock acquisition rights issuance aims to enhance motivation among employees and officers and to increase corporate value. While it may lead to shareholder dilution, it is expected to contribute to long-term corporate value enhancement. The allotment has not yet been exercised, and future exercise and impact will depend on stock price movements and performance.","jir_financial_highlights":"Number of Stock Acquisition Rights Allotted: 2,180 shares (Unknown)\nAllotment Scheduled Date: June 12, 2026 (Unknown)\nExercise Period: From June 13, 2028, to June 12, 2033 (Unknown)","jir_category":"","jir_hashtags":"#XebioHoldings, #IRRelated, #JapanStocks","jir_key_figures":"Number of stock acquisition rights allotted: 2,180 shares\nAllotment scheduled date: June 12, 2026\nExercise period: From June 13, 2028, to June 12, 2033","jir_meta_title":"\u3010Xebio Holdings\u3011Stock Option Grant\uff5cJune 2026","jir_meta_description":"Xebio Holdings will allocate 2,180 stock acquisition rights to 58 individuals in June 2026, with an exercise period from 2028 to 2033. The purpose is to improve performance and increase corporate value.","jir_og_title":"\u3010Xebio HD\u3011Stock Option Grant\uff5cJune 2026","jir_og_description":"Xebio Holdings allocated stock acquisition rights in June 2026 to incentivize employees and officers.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":17366,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"share_option","footnotes":""},"sector":[],"importance":[],"class_list":["post-61531","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n